T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.01B |
| 2 |
Broadcom
AVGO
|
+$1.49B |
| 3 |
GE Vernova
GEV
|
+$1.19B |
| 4 |
International Paper
IP
|
+$1.05B |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$952M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.31B |
| 2 |
Constellation Energy
CEG
|
+$1.94B |
| 3 |
Qualcomm
QCOM
|
+$1.74B |
| 4 |
NVIDIA
NVDA
|
+$1.71B |
| 5 |
Salesforce
CRM
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.98% |
| 2 | Healthcare | 14.89% |
| 3 | Financials | 10.35% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Communication Services | 9.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Moderna
MRNA
$25.4B
| $190M | 0.02% |
1,599,728
+580,531
| +57% | +$73.5M |
|
427
KeyCorp
KEY
$24.5B
| $189M | 0.02% |
13,288,327
+12,025,958
| +953% | +$174M |
|
428
Mattel
MAT
$4.19B
| $189M | 0.02% |
11,607,955
-77,336
| -0.7% | -$1.4M |
|
429
Otis Worldwide
OTIS
$28.2B
| $188M | 0.02% |
1,955,548
-309,701
| -14% | -$29.8M |
|
430
Lockheed Martin
LMT
$140B
| $188M | 0.02% |
401,927
-40,923
| -9% | -$18.9M |
|
431
Ionis Pharmaceuticals
IONS
$9.39B
| $188M | 0.02% |
3,934,311
+412,108
| +12% | +$16.9M |
|
432
Flowers Foods
FLO
$1.52B
| $187M | 0.02% |
8,428,721
-2,517,536
| -23% | -$59.6M |
|
433
Eaton
ETN
$179B
| $186M | 0.02% |
591,948
+15,291
| +3% | +$4.94M |
|
434
Teradyne
TER
$63B
| $185M | 0.02% |
1,248,857
+866,593
| +227% | +$110M |
|
435
NiSource
NI
$20.1B
| $185M | 0.02% |
6,404,978
+2,650,856
| +71% | +$74.8M |
|
|
TEM
436
Tempus AI
TEM
$9.85B
| $183M | 0.02% |
+5,227,120
| New | +$160M |
|
437
CMS Energy
CMS
$22B
| $180M | 0.02% |
3,031,357
-588,618
| -16% | -$35.6M |
|
438
3M
MMM
$94.8B
| $180M | 0.02% |
1,763,216
-779,168
| -31% | -$76M |
|
439
Middleby
MIDD
$5.38B
| $177M | 0.02% |
1,447,062
-3,159
| -0.2% | -$428K |
|
440
ScottsMiracle-Gro
SMG
$3.62B
| $177M | 0.02% |
2,722,410
-3,928
| -0.1% | -$269K |
|
441
Centene
CNC
$33.1B
| $177M | 0.02% |
2,671,085
-2,778,827
| -51% | -$202M |
|
442
Tyler Technologies
TYL
$13B
| $177M | 0.02% |
352,011
-72,971
| -17% | -$33.6M |
|
443
Crown Castle
CCI
$31.5B
| $175M | 0.02% |
1,786,542
+3,522
| +0.2% | +$347K |
|
444
Dentsply Sirona
XRAY
$2.27B
| $175M | 0.02% |
7,006,827
+740,046
| +12% | +$21.2M |
|
445
Waste Management
WM
$90.5B
| $173M | 0.02% |
811,643
+278,824
| +52% | +$58M |
|
446
Main Street Capital
MAIN
$5.47B
| $172M | 0.02% |
3,413,526
-25,820
| -0.8% | -$1.26M |
|
447
EastGroup Properties
EGP
$10.9B
| $172M | 0.02% |
1,013,051
+37,601
| +4% | +$6.22M |
|
448
Voya Financial
VOYA
$9.01B
| $172M | 0.02% |
2,416,956
+48,771
| +2% | +$3.51M |
|
449
Cognizant
CTSH
$26.2B
| $172M | 0.02% |
2,522,379
+618,116
| +32% | +$41.9M |
|
450
Aramark
ARMK
$15.9B
| $169M | 0.02% |
4,952,948
+4,786,359
| +2,873% | +$155M |
|
Similar funds
T. Rowe Price Associates's Q2 2024 Portfolio in Review
As of Q2 2024, T. Rowe Price Associates held 3,089 positions worth $836B, up 2.4% from $816B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
T. Rowe Price Associates's Q2 2024 filing shows 135 new, 1,850 increased, 836 reduced and 113 closed positions. Its largest new stake was Tempus AI: 5,227,120 shares worth $183M. The largest sale was Microsoft, an estimated $2.31B.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2024 buy was Tempus AI: 5,227,120 shares worth $183M.
- T. Rowe Price Associates added most to Apple in Q2 2024, an estimated $4.01B increase.
- T. Rowe Price Associates's biggest Q2 2024 reduction was Microsoft, cutting an estimated $2.31B.
- T. Rowe Price Associates fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $570M.
- T. Rowe Price Associates's ten largest holdings make up 36% of its $836B portfolio in Q2 2024.
- T. Rowe Price Associates opened 135 new positions and closed 113 in Q2 2024.
- T. Rowe Price Associates's portfolio value rose 2.4% quarter-over-quarter to $836B.
Based on T. Rowe Price Associates's 13F filing for Q2 2024, filed 14 Aug 2024.